Home   »   BioAsia 2020 announces Genome Valley Excellence...

BioAsia 2020 announces Genome Valley Excellence Award

BioAsia 2020 announces Genome Valley Excellence Award_4.1

BioAsia 2020 has announced the Genome Valley Excellence Award. American immunologist and oncologist Dr. Carl H June and Novartis CEO Dr. Vasant Narsimhan will be presented this award for their contributions to life sciences. The function will be organized by the Telangana government annual global biotechnology & life sciences forum.

Dr. Carl H June will be awarded for his work in immunotherapy, research in development of CAR-T (Chimeric Antigen Receptor- T cells) for treatment of cancer & commercialization of world’s first FDA (Food and Drug Administration, United States)- approved gene therapy.

Dr. Narasimhan has been selected for his new vision in the pharmaceutical business in digital technology and healthcare. He also worked in the development of 20 novel medicines, including advanced cells, gene therapy as well as vaccines and also worked on the public health issues particularly in developing countries.

Important takeaways for all competitive exams:

  • Chief Minister (CM): Kalvakuntla Chandrashekar Rao.
  • Governor of Telangana: Dr. Tamilisai Soundararajan.
  • Capital of Telangana: Hyderabad.

BioAsia 2020 announces Genome Valley Excellence Award_5.1

Find More Awards Here

BioAsia 2020 announces Genome Valley Excellence Award_6.1
About the Author

As a team lead and current affairs writer at Adda247, my role involves researching and creating informative and engaging content aimed at helping candidates prepare for national and state-level competitive government exams. I specialize in delivering insightful articles that keep aspirants updated on the latest current affairs trends and developments. My primary focus is on educational excellence, ensuring that our readers are well-prepared and informed to face their exams with confidence. Through meticulously crafted content, I aim to guide and support candidates in their journey toward success.